𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Application of induced pluripotent stem (iPS) cells in periodontal tissue regeneration

✍ Scribed by Xuejing Duan; Qisheng Tu; Jin Zhang; Jinhai Ye; Cesar Sommer; Gustavo Mostoslavsky; David Kaplan; Pishan Yang; Jake Chen


Publisher
John Wiley and Sons
Year
2010
Tongue
English
Weight
445 KB
Volume
226
Category
Article
ISSN
0021-9541

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Tissue engineering provides a new paradigm for periodontal tissue regeneration in which proper stem cells and effective cellular factors are very important. The objective of this study was, for the first time, to investigate the capabilities and advantages of periodontal tissue regeneration using induced pluripotent stem (iPS) cells and enamel matrix derivatives (EMD). In this study the effect of EMD gel on iPS cells in vitro was first determined, and then tissue engineering technique was performed to repair periodontal defects in three groups: silk scaffold only; silk scaffold + EMD; and silk scaffold + EMD + iPS cells. EMD greatly enhanced the mRNA expression of Runx2 but inhibited the mRNA expression of OC and mineralization nodule formation in vitro. Transplantation of iPS cells showed higher expression levels of OC, Osx, and Runx2 genes, both 12 and 24 days postsurgery. At 24 days postsurgery in the iPS cell group, histological analysis showed much more new alveolar bone and cementum formation with regenerated periodontal ligament between them. The results showed the commitment role that EMD contributes in mesenchymal progenitors to early cells in the osteogenic lineage. iPS cells combined with EMD provide a valuable tool for periodontal tissue engineering, by promoting the formation of new cementum, alveolar bone, and normal periodontal ligament. J. Cell. Physiol. 226: 150–157, 2010. Β© 2010 Wiley‐Liss, Inc.


πŸ“œ SIMILAR VOLUMES


Reprogramming the pluripotent cell cycle
✍ Prachi N. Ghule; Ricardo Medina; Christopher J. Lengner; Matthew Mandeville; Men πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 461 KB πŸ‘ 2 views

## Abstract Induced pluripotent stem (iPS) cells derived from terminally differentiated human fibroblasts are reprogrammed to possess stem cell like properties. However, the extent to which iPS cells exhibit unique properties of the human embryonic stem (hES) cell cycle remains to be established. h

Derivation of murine induced pluripotent
✍ Feng Li; Sarah Bronson; Christopher Niyibizi πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 418 KB πŸ‘ 1 views

## Abstract Induced pluripotent stem cells (iPSCs) have generated hope and excitement because of the potential they possess for generating patient‐specific embryonic‐like stem cells (ESCs). Although many hurdles remain to be solved before the cells can be applied clinically; studies directed toward

Human hair follicle pluripotent stem (hf
✍ Yasuyuki Amoh; Maho Kanoh; Shiro Niiyama; Yuko Hamada; Katsumasa Kawahara; Yuich πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 291 KB πŸ‘ 1 views

## Abstract The optimal source of stem cells for regenerative medicine is a major question. Embryonic stem (ES) cells have shown promise for pluripotency but have ethical issues and potential to form teratomas. Pluripotent stem cells have been produced from skin cells by either viral‐, plasmid‐ or

The therapeutic applications of multipot
✍ Agnieszka Arthur; Andrew Zannettino; Stan Gronthos πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 241 KB πŸ‘ 1 views

## Abstract Four decades after the first isolation and characterization of clonogenic bone marrow stromal cells or mesenchymal stem cells (MSC) in the laboratory of Dr. Alexander Friedenstien, the therapeutic application of their progeny following ex vivo expansion are only now starting to be reali